Year: 2025

Share repurchase programme: Transactions of week 52 2025

Written by Customer Service on December 29, 2025. Posted in Public Companies.

The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program: Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 2,986,009 655.96 1,958,706,33522 December 2025 15,000 857.17 12,857,58223...

Wereldhave sells Sterrenburg in Dordrecht, successfully completes Ville2 acquisition and secures new long-term financing

Written by Customer Service on December 29, 2025. Posted in Mergers And Acquisitions.

Wereldhave announces the sale of Full Service Center Sterrenburg in Dordrecht (The Netherlands), the successful completion of the acquisition of Ville2 in Charleroi (Belgium) and new long-term financing for Wereldhave Belgium. These transactions, plus related valuation synergies, further strengthen Wereldhave’s balance sheet. Disposal of Sterrenburg in DordrechtFull Service Center Sterrenburg in Dordrecht has been sold to a fund managed by Pertinea, an independent Belgian real estate investment services firm. Gross proceeds from the transaction amount to € 60 million, excluding transfer tax, reflecting the book value of the asset. Transfer of the asset took place on 24 December 2025. The sale of Sterrenburg marks the completion of Wereldhave’s planned disposal program in the Netherlands. Successful completion of Ville2 acquisitionIn addition,...

CEA Industries (BNC) Adopts Stockholder Rights Plan and Amended and Restated Bylaws in Response to YZi Labs Group Formation

Written by Customer Service on December 29, 2025. Posted in Public Companies.

Rights plan protects the Company and its stockholders from a change of control without a control premium Amended and Restated Bylaws ensure orderly and informed consent solicitation LOUISVILLE, CO, Dec. 28, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (the “Company” or “BNC”), which manages the world’s largest corporate treasury of BNB, today announced that its Board of Directors (the “Board”) unanimously adopted a limited duration stockholder rights agreement (the “Rights Plan”) and amended and restated bylaws (the “Amended and Restated Bylaws”) on December 26, 2025. The Board adopted the Rights Plan and the Amended and Restated Bylaws following the formation of a stockholder group (together, the “YZi Labs Group”) by YZILabs Management Ltd. (“YZi Labs”) that seeks control of the Company. As previously confirmed by...

Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics

Written by Customer Service on December 29, 2025. Posted in Public Companies.

PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) — Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announced it has entered into a strategic collaboration and non-exclusive licensing agreement with EirGenix Inc. (“EirGenix”) (TWSE: 6589), a global biopharmaceutical development and manufacturing company. Under the agreement, Transcenta will grant EirGenix a non-exclusive license to use its Highly Intensified Continuous Bioprocessing (HiCB) platform, including highly productive continuous perfusion and integrated hybrid continuous purification process technologies, along with comprehensive process documentation, know-how,...

Weebit Nano secures a license agreement with Texas Instruments

Written by Customer Service on December 28, 2025. Posted in Public Companies.

Global semiconductor leader licenses Weebit’s non-volatile memory (NVM) IP for some of its products HOD HASHARON, Israel, Dec. 28, 2025 (GLOBE NEWSWIRE) — Weebit Nano Limited (ASX:WBT) (Weebit or Company), a leading developer and licensor of advanced memory technologies for the global semiconductor industry, announced it has licensed its resistive random access memory (ReRAM) technology to Texas Instruments (TI), a global semiconductor company that designs, manufactures and sells analog and embedded processing chips. Under the terms of the agreement, Weebit’s ReRAM technology will be integrated into TI’s advanced process nodes for embedded processing semiconductors. The agreement includes IP licensing, technology transfer, design and qualification of Weebit ReRAM in TI’s process technologies. Weebit ReRAM is a low-power, cost-effective...

Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board

Written by Customer Service on December 27, 2025. Posted in Public Companies.

MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer, and Chairman of the Board of Directors. Victor passed away at the age of 87 following a brief illness. He was a deeply respected and admired leader and a mentor to the entire Senvest family. He will be greatly missed. Richard Mashaal, Director and Vice-President of the Corporation, stated: “We all mourn the loss of a great man. My father founded the Corporation in 1968. The firm began with an initial investment of $10,000 to purchase the Canadian rights to Sensormatic Electronics Corporation’s anti-shoplifting products. He pioneered this industry in Canada, as well as the Canadian...

MEDIROM Partners with World

Written by Customer Service on December 26, 2025. Posted in Public Companies.

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex BlaniaTOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), a diversified healthcare company, is collaborating with World Foundation and Tools for Humanity to deploy Proof of Human technologies such as World ID throughout Japan. The World project was co-created by Sam Altman and Alex Blania. In preparation for the full-scale rollout of the World project in Japan, MEDIROM has entered into a Master Service Agreement (“MSA”) with Tools for Humanity (“TFH”) and World Foundation (“WF”). Under the MSA, the MEDIROM Group will be responsible for the operation of “Proof of Human” verification locations in Japan. This...

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)

Written by Customer Service on December 26, 2025. Posted in Public Companies.

NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) — Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025, pursuant to securities laws, it disposed of beneficial ownership of 1,000,000 common shares (a “Common Share”) of Fennec Pharmaceuticals Inc. (“Fennec”), representing approximately 2.93% of the outstanding Common Shares (calculated on a fully diluted basis). The Common Shares were sold at a price of USD$7.50 per Common Share. Southpoint now exercises control or direction over an aggregate of 2.7 million Common Shares, and representing approximately 8% of the outstanding Common Shares (calculated on a fully diluted basis). Southpoint has disposed of the Common Shares for investment purposes. Depending on market and other...

Outlook Therapeutics Announces New Employment Inducement Grants

Written by Customer Service on December 26, 2025. Posted in Public Companies.

ISELIN, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that effective December 19, 2025, the Outlook Therapeutics, Inc. Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 150,000 shares of Outlook Therapeutics common stock with a per share exercise price of $2.01 per share to two new employees. The above-described awards were granted as an inducement material to the employees entering into employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). About Outlook Therapeutics, Inc. Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™...

Brookfield Real Assets Income Fund Inc. Declares Q1 2026 Distribution Schedule

Written by Customer Service on December 26, 2025. Posted in Dividend Reports And Estimates.

NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) — Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund’s monthly distributions for January, February and March 2026. Q1 2026 Distribution ScheduleMonth Record Date Ex-Dividend Date Payable Date Amount per ShareJanuary 2026 January 8, 2026 January 8, 2026 January 22, 2026 $0.1180February 2026 February 5, 2026 February 5, 2026 February 19, 2026 $0.1180March 2026 March 12, 2026 March 12, 2026 March 26, 2026 $0.1180Shares purchased on or after the applicable ex-distribution dates will not receive the distributions discussed above. Distributions may include net investment income, capital gains and/or return of capital. Any portion of the Fund’s distributions that is a return of capital does not...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals